循環性腫瘤細胞市場規模、佔有率及成長分析（依技術、應用、產品、檢體、最終用途及地區）－2025-2032 年產業預測

2023 年全球循環性腫瘤細胞市場規模價值 122 億美元，預計將從 2024 年的 135.5 億美元成長到 2032 年的 314.6 億美元，預測期內（2025-2032 年）的複合年成長率為 11.1%。

由於癌症診斷技術的創新和癌症發生率的上升，全球循環性腫瘤細胞(CTC) 市場正在經歷動態成長。對非侵入性診斷工具（尤其是 CTC 分析）的需求受到個人化醫療的轉變和早期癌症檢測的迫切需求的推動。然而，技術複雜性和缺乏標準化等挑戰阻礙了其更廣泛的應用。目前以ELISA和PCR方法是主流產品。北美憑藉其強大的醫療保健基礎設施佔據了很大的市場佔有率。該市場的特點是持續的研究舉措、合作和創新產品開發，旨在應對不斷變化的醫療保健格局並改善患者的治療效果。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

循環性腫瘤細胞市場規模（依技術及複合年成長率） (2025-2032)

• 市場概覽
• CTC檢測和富集方法
  • 免疫捕獲（基於標記）
  • 正向選擇
  • 負面選擇
  • 尺寸分離（無標定）
  • 基於膜
  • 基於微流體
  • 基於密度的分離（無標定）
  • 組合法
• 直接CTC檢測方法
  • SERS
  • 顯微鏡
  • 其他
• CTC分析

循環性腫瘤細胞市場規模（依應用）及複合年成長率（2025-2032）

• 市場概覽
• 臨床/液態生物檢體
  • 風險評估
  • 篩檢和監測
• 調查
  • 研究癌症幹細胞和腫瘤發生
  • 藥物和治療方法開發

循環性腫瘤細胞市場規模（按產品和複合年成長率） (2025-2032)

• 市場概覽
• 套件和試劑
• 採血管
• 設備或系統

循環性腫瘤細胞市場規模（檢體和複合年成長率） (2025-2032)

• 市場概覽
• 血
• 骨髓
• 其他體液

循環性腫瘤細胞市場規模（依最終用途和複合年成長率） (2025-2032)

• 市場概覽
• 研究和學術機構
• 醫院和診所
• 診斷中心

循環性腫瘤細胞市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
• 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Sysmex Corporation（Japan）
• Bio-Techne Corporation（USA）
• Thermo Fisher Scientific Inc.（USA）
• Miltenyi Biotec GmbH（Germany）
• Biolidics Limited（Singapore）
• ScreenCell（France）
• Greiner Bio-One International GmbH（Austria）
• AVIVA Biosciences（USA）
• BIOCEPT, Inc.（USA）
• Ikonisys, Inc.（USA）
• Epic Sciences（USA）
• Rarecells Diagnostics（France）
• STEMCELL Technologies, Inc.（Canada）
• Precision for Medicine（USA）
• ANGLE plc（UK）
• Creatv MicroTech, Inc.（USA）

結論和建議

Global Circulating Tumor Cell Market size was valued at USD 12.2 billion in 2023 and is poised to grow from USD 13.55 billion in 2024 to USD 31.46 billion by 2032, growing at a CAGR of 11.1% during the forecast period (2025-2032).

The global Circulating Tumor Cell (CTC) market is witnessing dynamic growth, driven by innovations in cancer diagnostics and an increasing incidence of cancer. The demand for non-invasive diagnostic tools, particularly CTC analysis, is fueled by a shift towards personalized medicine and a pressing need for early cancer detection. However, challenges such as technological complexities and the lack of standardization hinder broader adoption. Currently, ELISA and PCR-based methods dominate the product landscape. North America commands a significant market share attributed to its robust healthcare infrastructure. The market is characterized by continuous research initiatives, collaborative efforts, and innovative product developments aimed at addressing the evolving medical landscape and enhancing patient outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Circulating Tumor Cell market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Circulating Tumor Cell Market Segments Analysis

Global Circulating Tumor Cell Market is segmented by Technology, Application, Product, Specimen, End Use and region. Based on Technology, the market is segmented into CTC detection & enrichment methods, CTC Direct Detection Methods and CTC Analysis. Based on Application, the market is segmented into Clinical/ Liquid Biopsy and Research. Based on Product, the market is segmented into Kits & Reagents, Blood Collection Tubes and Devices or Systems. Based on specimen, the market is segmented into Blood, Bone Marrow and Other Body Fluids. Based on End Use, the market is segmented into Research and academic institutes, Hospital and clinics and Diagnostic centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Circulating Tumor Cell Market

The rising incidence of cancer worldwide has intensified the demand for advanced diagnostic tools, with circulating tumor cell (CTC) analysis gaining prominence as a non-invasive and valuable technique for cancer detection and monitoring. Additionally, the focus on personalized medicine and the urgency for early cancer diagnosis are driving the adoption of CTC technologies. This growing need for effective diagnostic solutions is reshaping the global landscape of cancer management and treatment, fostering innovation and advancements in the CTC market, which aims to provide better outcomes for patients through improved detection and monitoring capabilities.

Restraints in the Global Circulating Tumor Cell Market

One of the primary challenges facing the global circulating tumor cell (CTC) market is the technological complexity involved in CTC analysis. This intricacy complicates the process and highlights the need for standardization across various methodologies, which hinders widespread acceptance and implementation. Furthermore, concerns regarding the reliability and reproducibility of CTC results create additional barriers, making it difficult for these techniques to be integrated into standard clinical practices. As such, these factors collectively contribute to limiting the overall growth and adoption of CTC technologies in the healthcare sector, restraining market potential.

Market Trends of the Global Circulating Tumor Cell Market

The global circulating tumor cell (CTC) market is witnessing a significant trend characterized by the increasing integration of CTC analysis into routine clinical practice. This shift is driven by the technology's ability to facilitate real-time cancer progression tracking and treatment response evaluation. Advances in innovative technologies such as microfluidic systems and sophisticated molecular detection techniques are enhancing the precision and sensitivity of CTC analysis. Additionally, the rising awareness and adoption of liquid biopsy methods for cancer diagnostics underscore the critical role of CTCs as valuable biomarkers. This convergence of technology and clinical application is poised to revolutionize cancer care and diagnosis.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Circulating Tumor Cell Market Size by Technology & CAGR (2025-2032)

• Market Overview
• CTC detection & enrichment methods
  • Immunocapture (label-based)
  • Positive selection
  • Negative selection
  • Size-based separation (label-free)
  • Membrane-based
  • Microfluidic-based
  • Density-based separation (label-free)
  • Combined methods
• CTC Direct Detection Methods
  • SERS
  • Microscopy
  • Others
• CTC Analysis

Global Circulating Tumor Cell Market Size by Application & CAGR (2025-2032)

• Market Overview
• Clinical/ Liquid Biopsy
  • Risk Assessment
  • Screening and Monitoring
• Research
  • Cancer stem cell & tumorogenesis research
  • Drug/therapy development

Global Circulating Tumor Cell Market Size by Product & CAGR (2025-2032)

• Market Overview
• Kits & Reagents
• Blood Collection Tubes
• Devices or Systems
• Global Circulating Tumor Cell Market Size by Specimen & CAGR (2025-2032)
• Market Overview
• Blood
• Bone Marrow
• Other Body Fluids

Global Circulating Tumor Cell Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Research and academic institutes
• Hospital and clinics
• Diagnostic centers

Global Circulating Tumor Cell Market Size & CAGR (2025-2032)

• North America (Technology, Application, Product, Specimen, End Use)
  • US
  • Canada
• Europe (Technology, Application, Product, Specimen, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Technology, Application, Product, Specimen, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Technology, Application, Product, Specimen, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Technology, Application, Product, Specimen, End Use)
  • GCC Countries
• South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biolidics Limited (Singapore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ScreenCell (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Greiner Bio-One International GmbH (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AVIVA Biosciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BIOCEPT, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ikonisys, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Epic Sciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rarecells Diagnostics (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• STEMCELL Technologies, Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Precision for Medicine (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ANGLE plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creatv MicroTech, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations